Skip to main content
. Author manuscript; available in PMC: 2024 May 1.
Published in final edited form as: Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2022 Nov 21;15(3):e1870. doi: 10.1002/wnan.1870

Figure 2.

Figure 2

DC interact with the nanovaccine followed by the process of antigen presentation through CD40 and MHC II. Post attachment and antigen presentation of nanocarrier, maturation and migration of DC cell results in regulatory T cell activation in lymph nodes. This further results in immune memory activation via T and B cells.